Evaporative Dry Eye - The Often Overlooked Consequence of Meibomian Gland Dysfunction

Dry eye is a common condition that affects millions of people worldwide, causing discomfort, irritation, and even blurry vision. One often overlooked cause of dry eye is evaporative dry eye (EDE) resulting from meibomian gland dysfunction (MGD)

Meibomian glands are tiny, oil-producing glands located within the eyelids. They are responsible for producing the oily layer of the tear film that prevents excessive evaporation and maintains the overall stability of the tear film. MGD occurs when the meibomian glands become obstructed or produce poor-quality meibum (the oily substance), leading to tear film instability and, consequently, EDE.

EDE often goes undiagnosed or overlooked as people generally associate dry eye with aqueous deficiency, which is caused by reduced production of the watery layer of the tear film. However, it's essential to recognize that MGD can be a significant contributor to dry eye symptoms, and early diagnosis and treatment can provide relief and prevent further complications.

One common treatment for MGD is meibomian gland expression. This procedure involves applying gentle pressure to the eyelids to express the stagnant meibum and clear the blockage in the glands. An optometrist typically performs this procedure using specialized instruments. Gland expression can provide immediate relief from symptoms and improve the tear film's quality, but it may need to be repeated periodically, depending on the severity of the condition.

Oral supplements, particularly those containing omega-3 fatty acids, have been shown to improve MGD symptoms and overall tear film quality. Omega-3 fatty acids, found in fish oil and flaxseed oil, can help reduce inflammation in the meibomian glands and improve their function. Studies have shown that consistent supplementation can lead to long-term improvement in tear film stability and a reduction in dry eye symptoms.

Intense pulsed light (IPL) therapy is a relatively new and promising treatment for MGD. IPL uses bursts of high-intensity light to target and reduce inflammation in the meibomian glands, improving their function and tear film quality. This non-invasive treatment is typically performed in a series of sessions over several weeks, and the results can be long-lasting. Some patients may require maintenance treatments every 6 to 12 months to maintain optimal results.

Despite its significant role in causing dry eye symptoms, MGD is often overlooked for several reasons. First, dry eye is a multifactorial condition, and many healthcare providers may focus on the more commonly known aqueous deficiency. Second, the symptoms of MGD can be nonspecific and may mimic those of other eye conditions, making it challenging to diagnose accurately. Lastly, some patients may not report their symptoms to their healthcare provider, either because they are mild or because they attribute them to other causes, such as allergies or contact lens use.